[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

United States Human Prothrombin Complex Market Report 2016

December 2016 | 99 pages | ID: U6A8C280BC3EN
QYResearch

US$ 3,800.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Notes:

Sales, means the sales volume of Human Prothrombin Complex

Revenue, means the sales value of Human Prothrombin Complex

This report studies sales (consumption) of Human Prothrombin Complex in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering
  • Baxter
  • CSL
  • Bayer
  • Grifols
  • Octapharma
  • Shanghai RAAS
  • Hualan Biological
Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into
  • 100 IU/Vial
  • 200 IU/Vial
  • 300 IU/Vial
  • 400 IU/Vial
  • 1000 IU/Vial
Split by applications, this report focuses on sales, market share and growth rate of Human Prothrombin Complex in each application, can be divided into
  • Hemophilia B
  • Anticoagulant Overdose
  • Vitamin K Deficiency
  • Due to Liver Disease Caused by Coagulation Disorders
United States Human Prothrombin Complex Market Report 2016

1 HUMAN PROTHROMBIN COMPLEX OVERVIEW

1.1 Product Overview and Scope of Human Prothrombin Complex
1.2 Classification of Human Prothrombin Complex
  1.2.1 100 IU/Vial
  1.2.2 200 IU/Vial
  1.2.3 300 IU/Vial
  1.2.4 400 IU/Vial
  1.2.5 1000 IU/Vial
1.3 Application of Human Prothrombin Complex
  1.3.1 Hemophilia B
  1.3.2 Anticoagulant Overdose
  1.3.3 Vitamin K Deficiency
  1.3.4 Due to Liver Disease Caused by Coagulation Disorders
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Human Prothrombin Complex (2011-2021)
  1.4.1 United States Human Prothrombin Complex Sales and Growth Rate (2011-2021)
  1.4.2 United States Human Prothrombin Complex Revenue and Growth Rate (2011-2021)

2 UNITED STATES HUMAN PROTHROMBIN COMPLEX COMPETITION BY MANUFACTURERS

2.1 United States Human Prothrombin Complex Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Human Prothrombin Complex Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Human Prothrombin Complex Average Price by Manufactures (2015 and 2016)
2.4 Human Prothrombin Complex Market Competitive Situation and Trends
  2.4.1 Human Prothrombin Complex Market Concentration Rate
  2.4.2 Human Prothrombin Complex Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 UNITED STATES HUMAN PROTHROMBIN COMPLEX SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2011-2016)

3.1 United States Human Prothrombin Complex Sales and Market Share by Type (2011-2016)
3.2 United States Human Prothrombin Complex Revenue and Market Share by Type (2011-2016)
3.3 United States Human Prothrombin Complex Price by Type (2011-2016)
3.4 United States Human Prothrombin Complex Sales Growth Rate by Type (2011-2016)

4 UNITED STATES HUMAN PROTHROMBIN COMPLEX SALES (VOLUME) BY APPLICATION (2011-2016)

4.1 United States Human Prothrombin Complex Sales and Market Share by Application (2011-2016)
4.2 United States Human Prothrombin Complex Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities

5 UNITED STATES HUMAN PROTHROMBIN COMPLEX MANUFACTURERS PROFILES/ANALYSIS

5.1 Baxter
  5.1.1 Company Basic Information, Manufacturing Base and Competitors
  5.1.2 Human Prothrombin Complex Product Type, Application and Specification
    5.1.2.1 Type I
    5.1.2.2 Type II
  5.1.3 Baxter Human Prothrombin Complex Sales, Revenue, Price and Gross Margin (2011-2016)
  5.1.4 Main Business/Business Overview
5.2 CSL
  5.2.2 Human Prothrombin Complex Product Type, Application and Specification
    5.2.2.1 Type I
    5.2.2.2 Type II
  5.2.3 CSL Human Prothrombin Complex Sales, Revenue, Price and Gross Margin (2011-2016)
  5.2.4 Main Business/Business Overview
5.3 Bayer
  5.3.2 Human Prothrombin Complex Product Type, Application and Specification
    5.3.2.1 Type I
    5.3.2.2 Type II
  5.3.3 Bayer Human Prothrombin Complex Sales, Revenue, Price and Gross Margin (2011-2016)
  5.3.4 Main Business/Business Overview
5.4 Grifols
  5.4.2 Human Prothrombin Complex Product Type, Application and Specification
    5.4.2.1 Type I
    5.4.2.2 Type II
  5.4.3 Grifols Human Prothrombin Complex Sales, Revenue, Price and Gross Margin (2011-2016)
  5.4.4 Main Business/Business Overview
5.5 Octapharma
  5.5.2 Human Prothrombin Complex Product Type, Application and Specification
    5.5.2.1 Type I
    5.5.2.2 Type II
  5.5.3 Octapharma Human Prothrombin Complex Sales, Revenue, Price and Gross Margin (2011-2016)
  5.5.4 Main Business/Business Overview
5.6 Shanghai RAAS
  5.6.2 Human Prothrombin Complex Product Type, Application and Specification
    5.6.2.1 Type I
    5.6.2.2 Type II
  5.6.3 Shanghai RAAS Human Prothrombin Complex Sales, Revenue, Price and Gross Margin (2011-2016)
  5.6.4 Main Business/Business Overview
5.7 Hualan Biological
  5.7.2 Human Prothrombin Complex Product Type, Application and Specification
    5.7.2.1 Type I
    5.7.2.2 Type II
  5.7.3 Hualan Biological Human Prothrombin Complex Sales, Revenue, Price and Gross Margin (2011-2016)
  5.7.4 Main Business/Business Overview

6 HUMAN PROTHROMBIN COMPLEX MANUFACTURING COST ANALYSIS

6.1 Human Prothrombin Complex Key Raw Materials Analysis
  6.1.1 Key Raw Materials
  6.1.2 Price Trend of Key Raw Materials
  6.1.3 Key Suppliers of Raw Materials
  6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
  6.2.1 Raw Materials
  6.2.2 Labor Cost
  6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Human Prothrombin Complex

7 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

7.1 Human Prothrombin Complex Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Human Prothrombin Complex Major Manufacturers in 2015
7.4 Downstream Buyers

8 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

8.1 Marketing Channel
  8.1.1 Direct Marketing
  8.1.2 Indirect Marketing
  8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
  8.2.1 Pricing Strategy
  8.2.2 Brand Strategy
  8.2.3 Target Client
8.3 Distributors/Traders List

9 MARKET EFFECT FACTORS ANALYSIS

9.1 Technology Progress/Risk
  9.1.1 Substitutes Threat
  9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change

10 UNITED STATES HUMAN PROTHROMBIN COMPLEX MARKET FORECAST (2016-2021)

10.1 United States Human Prothrombin Complex Sales, Revenue Forecast (2016-2021)
10.2 United States Human Prothrombin Complex Sales Forecast by Type (2016-2021)
10.3 United States Human Prothrombin Complex Sales Forecast by Application (2016-2021)
10.4 Human Prothrombin Complex Price Forecast (2016-2021)

11 RESEARCH FINDINGS AND CONCLUSION

12 APPENDIX

Disclosure Section
Research Methodology
Data Source
Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.
LIST OF TABLES AND FIGURES

Figure Picture of Human Prothrombin Complex
Table Classification of Human Prothrombin Complex
Figure United States Sales Market Share of Human Prothrombin Complex by Type in 2015
Figure 100 IU/Vial Picture
Figure 200 IU/Vial Picture
Figure 300 IU/Vial Picture
Figure 400 IU/Vial Picture
Figure 1000 IU/Vial Picture
Table Application of Human Prothrombin Complex
Figure United States Sales Market Share of Human Prothrombin Complex by Application in 2015
Figure Hemophilia B Examples
Figure Anticoagulant Overdose Examples
Figure Vitamin K Deficiency Examples
Figure Due to Liver Disease Caused by Coagulation Disorders Examples
Figure United States Human Prothrombin Complex Sales and Growth Rate (2011-2021)
Figure United States Human Prothrombin Complex Revenue and Growth Rate (2011-2021)
Table United States Human Prothrombin Complex Sales of Key Manufacturers (2015 and 2016)
Table United States Human Prothrombin Complex Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Human Prothrombin Complex Sales Share by Manufacturers
Figure 2016 Human Prothrombin Complex Sales Share by Manufacturers
Table United States Human Prothrombin Complex Revenue by Manufacturers (2015 and 2016)
Table United States Human Prothrombin Complex Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Human Prothrombin Complex Revenue Share by Manufacturers
Table 2016 United States Human Prothrombin Complex Revenue Share by Manufacturers
Table United States Market Human Prothrombin Complex Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Human Prothrombin Complex Average Price of Key Manufacturers in 2015
Figure Human Prothrombin Complex Market Share of Top 3 Manufacturers
Figure Human Prothrombin Complex Market Share of Top 5 Manufacturers
Table United States Human Prothrombin Complex Sales by Type (2011-2016)
Table United States Human Prothrombin Complex Sales Share by Type (2011-2016)
Figure United States Human Prothrombin Complex Sales Market Share by Type in 2015
Table United States Human Prothrombin Complex Revenue and Market Share by Type (2011-2016)
Table United States Human Prothrombin Complex Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Human Prothrombin Complex by Type (2011-2016)
Table United States Human Prothrombin Complex Price by Type (2011-2016)
Figure United States Human Prothrombin Complex Sales Growth Rate by Type (2011-2016)
Table United States Human Prothrombin Complex Sales by Application (2011-2016)
Table United States Human Prothrombin Complex Sales Market Share by Application (2011-2016)
Figure United States Human Prothrombin Complex Sales Market Share by Application in 2015
Table United States Human Prothrombin Complex Sales Growth Rate by Application (2011-2016)
Figure United States Human Prothrombin Complex Sales Growth Rate by Application (2011-2016)
Table Baxter Basic Information List
Table Baxter Human Prothrombin Complex Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Baxter Human Prothrombin Complex Sales Market Share (2011-2016)
Table CSL Basic Information List
Table CSL Human Prothrombin Complex Sales, Revenue, Price and Gross Margin (2011-2016)
Table CSL Human Prothrombin Complex Sales Market Share (2011-2016)
Table Bayer Basic Information List
Table Bayer Human Prothrombin Complex Sales, Revenue, Price and Gross Margin (2011-2016)
Table Bayer Human Prothrombin Complex Sales Market Share (2011-2016)
Table Grifols Basic Information List
Table Grifols Human Prothrombin Complex Sales, Revenue, Price and Gross Margin (2011-2016)
Table Grifols Human Prothrombin Complex Sales Market Share (2011-2016)
Table Octapharma Basic Information List
Table Octapharma Human Prothrombin Complex Sales, Revenue, Price and Gross Margin (2011-2016)
Table Octapharma Human Prothrombin Complex Sales Market Share (2011-2016)
Table Shanghai RAAS Basic Information List
Table Shanghai RAAS Human Prothrombin Complex Sales, Revenue, Price and Gross Margin (2011-2016)
Table Shanghai RAAS Human Prothrombin Complex Sales Market Share (2011-2016)
Table Hualan Biological Basic Information List
Table Hualan Biological Human Prothrombin Complex Sales, Revenue, Price and Gross Margin (2011-2016)
Table Hualan Biological Human Prothrombin Complex Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Human Prothrombin Complex
Figure Manufacturing Process Analysis of Human Prothrombin Complex
Figure Human Prothrombin Complex Industrial Chain Analysis
Table Raw Materials Sources of Human Prothrombin Complex Major Manufacturers in 2015
Table Major Buyers of Human Prothrombin Complex
Table Distributors/Traders List
Figure United States Human Prothrombin Complex Production and Growth Rate Forecast (2016-2021)
Figure United States Human Prothrombin Complex Revenue and Growth Rate Forecast (2016-2021)
Table United States Human Prothrombin Complex Production Forecast by Type (2016-2021)
Table United States Human Prothrombin Complex Consumption Forecast by Application (2016-2021)


More Publications